Use of an immunotherapeutic vaccine to treat a life-threatening human arteritic infection caused by Pythium insidiosum

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1394-1400

  Thitithanyanont, Arunee ^b   Mendoza, Leonel ^a   Chuansumrit, Ampaiwan ^b   Pracharktam, Roongnapa ^b   Laothamatas, Jiraporn ^b   Sathapatayavongs, Boonmee ^b   Lolekha, Somsak ^b   Ajello, Libero ^b  

^a Michigan State University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FUNGUS VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; KETOCONAZOLE; POTASSIUM IODIDE;

ABSCESS; ADOLESCENT; ARTERITIS; ARTICLE; CAROTID ARTERY ANEURYSM; CASE REPORT; FACIAL NERVE PARALYSIS; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MANDIBLE; NUCLEAR MAGNETIC RESONANCE IMAGING; OOMYCETES; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 0032450129     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515043     Document Type: Article

References (34)

1. Schell W. New aspects of emerging fungal pathogens. Clin Lab Med 1995; 15:365-87.
2. Sternberg S. The emerging fungal threat. Science 1994; 266:1632-4.
3. Vazquez JA, Sobel D. Fungal infections in diabetes. Infect Dis Clin North Am 1995; 9:97-117.
4. Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 1995; 8:146-59.
5. Alexopoulos CJ, Mims CW, Blackwell M. Introductory mycology. 4th ed. New York: John Wiley & Sons, 1996:683-737.
6. Mendoza L, Ajello L, McGinnis MR. Infections caused by the oomycetous pathogen Pythium insidiosum. J Mycol Med 1996; 6:151-64.
7. Chetchotisakd P, Porntaveevudhi O, Mairiang P, et al. Human pythiosis in Srinagarind Hospital: one year's experience. J Med Assoc Thailand 1992; 75:248-54.
8. Sathapatayavongs B, Leelachaikul P, Prachaktham O, et al. Human pythiosis associated with thalassemia hemoglobinopathy syndrome. J Infect Dis 1989; 159:274-80.
9. Wanachiwanawin W, Thianprasit M, Fucharoen S, et al. A fatal arteritis due to Pythium insidiosum in patients with thalassaemia. Trans R Soc Trop Med Hyg 1993; 87:296-8.
10. Imwidthaya P. Mycotic keratitis in Thailand. J Med Vet Mycol 1995; 33: 81-2.
11. Rinaldi MG, Seidenfeld SM, Fotherbell AM, McGough BS. Pythium insidiosum causes severe disease in a healthy boy. Mycology Observer 1989; 9:7.
12. Virgile R, Perry HD, Pardanani B, et al. Human corneal ulcer caused by Pythium insidiosum. Cornea 1993; 12:81-3.
13. Imwidthaya P. Human pythiosis in Thailand. Postgrad Med J 1994; 70: 558-60.
14. Franco DM, Parr D. Pythium insidiosum keratitis. Aust NZ J Ophthalmol 1997; 25:177-9.
15. Thianprasit M. Human pythiosis. Trop Dermatol 1990; 4:1-4.
16. Triscott JA, Weedon D, Cabana E. Human subcutaneous pythiosis. J Cut Pathol 1993; 20:267-71.
17. Chaffin MK, Chumacher J, McMullan WC. Cutaneous pythiosis in the horse. Vet Clin North Am Equine Pract 1995; 11:91-103.
18. Thianprasit M, Chaiprasert A, Imwidthaya P. Human pythiosis. Curr Top Med Mycol 1996; 7:43-54.
19. Mendoza L, Alfaro AA. Equine pythiosis in Costa Rica: report of 39 cases. Mycopathologia 1986; 94:123-9.
20. Miller RI. Treatment of equine phycomycosis by immunotherapy and surgery. Aust Vet J 1981; 67:377-82.
21. Miller RJ, Wold D, Lindsay WA, Beadle RE, McClure JR, McCoy DJ. Complications associated with immunotherapy of equine phycomycosis. J Am Vet Med Assoc 1983; 182:1227-9.
22. Newton JC, Ross PS. Equine pythiosis: an overview of immunotherapy. Compendium 1993; 15:491-3.
23. Dixon DM, Casadevall A, Klein B, Mendoza L, Travassos L, Deep GS. Development of vaccines and their use in the prevention of fungal infections. Med Mycol 1998; 36:57-67.
24. Mendoza L, Kaufman L, Mandy W, Glass R. Serodiagnosis of human and animal pythiosis using an enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1997; 4:715-8.
25. Mendoza L, Nicholson V, Prescott JE. Immunoblot analysis of the humoral immune response to Pythium insidiosum in horses with pythiosis. J Clin Microbiol 1992; 30:2980-3.
26. Cohen J. Vaccines get a new twist. Science 1994; 264:503-5.
27. Deep GS. Prospects for the development of fungal vaccines. Clin Microbiol Rev 1997; 10:585-96.
28. Burke DS. Vaccine therapy for HIV: a historical review of the treatment of infectious diseases by active specific immunization with microbe-derived antigens. Vaccine 1993; 11:883-90.
29. Convit J, Ulrich M, Fernandez CT, et al. The clinical and immunological spectrum of American cutaneous leshmaniasis. Trans R Soc Trop Med Hyg 1993; 87:444.
30. Standford JL. The history and future of vaccination and immunotherapy for leprosy. Trop Geogr Med 1994; 46:93-107.
31. Gudding R, Lund A. Immunoprophylaxis of bovine dermatophytosis. Can Vet J 1995; 36:302-6.
32. Mendoza L, Villalobos J, Calleja CE, Solis A. Evaluation of two vaccines for the treatment of pythiosis insidiosi in horses. Mycopathologia 1992; 119:89-95.
33. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998; 19:157-63.
34. Julia V, Rassoulzadenga M, Glaichenhaus N. Resistance to Leishmania major induced by tolerance to a single antigen. Science 1996; 274: 421-3.